Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples Post author:Sam Post published:March 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer April 4, 2017 Pfizer Makes a $545 Million Deal With Another Bay Area Biotech, Sangamo May 10, 2017 Argentum And Eli Lilly Settle Patent Dispute Over CIALIS August 22, 2017
MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer April 4, 2017